Grant ID RP180466
Awarded On February 21, 2018
Title Integrated single-cell biomarkers of T-cell efficacy
Program Academic Research
Award Mechanism Individual Investigator Research Awards for Clinical Translation
Institution/Organization University of Houston
Principal Investigator/Program Director Navin Varadarajan
Cancer Sites Lymphoma
Contracted Amount $1,173,420
Lay Summary

Immunotherapy has revolutionized the treatment of cancers. Despite breakthrough progress, attaining predictable outcomes in the clinic is a largely unsolved problem. This proposal aims to study immune cells directly from patients undergoing treatment within Texas to identify biomarkers of responses. We anticipate that the discovery and validation of biomarkers optimal immune cells will ensure that more Texans benefit broadly from immunotherapy.